Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2022
Nov. 14, 2022
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2022  
Entity File Number 001-36641  
Entity Registrant Name BRAINSTORM CELL THERAPEUTICS INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 20-7273918  
Entity Address, Address Line One 1325 Avenue of Americas, 28th Floor  
Entity Address, City or Town NY  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10019  
City Area Code 201  
Local Phone Number 488-0460  
Title of 12(b) Security Common Stock, $0.00005 par value  
Trading Symbol BCLI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   36,541,779
Entity Central Index Key 0001137883  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false